LCB-76

N/A

Report date: 2023/02/18 19:46:36

Base Information

Drug NameLCB-76
Drug Alias NameLCB76LCB14-19nn
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-EGFRvIII
TargetsEpidermal growth factor receptor variant III
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLegochem Biosciences IncSamsung Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSamsung Medical CenterLegochem Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A